Maples and Calder Advises Biohaven Pharmaceutical on US$195m IPO Maples and Calder Advises Biohaven Pharmaceutical on US$195m IPO
01 Jun 2017
Maples and Calder has advised Biohaven Pharmaceutical Holding Company Ltd ("Biohaven") on its initial public offering ("IPO") on the New York Stock Exchange, which closed in May 2017 at approximately US$195 million.
The Maples and Calder team was led by BVI-based partners Richard May and Chris Newton with the assistance of associate Daniel Perkins. "Transactions such as these highlight the flexibility of the BVI as a jurisdiction and the suitability of BVI entities for a wide range of uses, including IPOs," said Maples and Calder's BVI Managing Partner, Richard May. "We are pleased to have assisted Biohaven on this significant achievement and look forward to continuing to work with them as the business progresses." A long standing client of the firm, Maples and Calder has acted as Biohaven's legal adviser since its incorporation and continues to advise the company on its corporate matters.
The Maples Group is proud to announce its support of the newly built music classrooms at Elmore Stoutt High School in the British Virgin Islands.Read more
20 Dec 2019
Maples and Calder, the Maples Group's law firm, is pleased to announce that it has achieved the highest rankings in The Legal 500 Caribbean 2020.Read more
17 Dec 2019
The Maples Group is pleased to announce that they have retained their Band 1 ranking in the Offshore category of the Asia Pacific Region in the Chambers Asia Pacific Directory 2020.Read more
11 Dec 2019
The Maples Group is pleased to announce a number of new leadership appointments following its biennial management elections.Read more
04 Dec 2019
Earlier this month, Maples and Calder, the Maples Group's law firm was honoured to win two prestigious awards at the annual HFM Asia Services Awards and China Offshore Awards.Read more
29 Nov 2019
Maples and Calder, the Maples Group's law firm was pleased to advise Alibaba Group Holding Limited on its recent global offering of 500,000,000 shares and its listing on the Hong Kong Stock Exchange. The offering is the largest in Hong Kong since 2010.Read more
22 Nov 2019